Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06603090 · ClinicalTrials.gov registry record · NA
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 66,147
- Enrollment target
NCT06603090 is a NA study that has completed, run by Columbia University. The registered enrollment target is 66,147 participants.
The verdict
NCT06603090, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66,147 participants
- Enrollment target
Study Summary
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
Interventions
- BEHAVIORAL Text message influenza vaccine reminders
- BEHAVIORAL Text message COVID-19 vaccine reminders
- BEHAVIORAL Text message influenza and COVID-19 vaccine reminders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66,147 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06603090
The ClinicalTrials.gov registry entry for NCT06603090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66,147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Text message influenza vaccine reminders is the first listed.
NCT06603090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06603090 about?
NCT06603090 is a clinical study titled "Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season". This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
What is the current status of trial NCT06603090?
This trial is currently completed. It is a NA study. The enrollment target is 66,147 participants. The study started on 2024-10-02. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06603090?
The interventions under investigation include: Text message influenza vaccine reminders (BEHAVIORAL), Text message COVID-19 vaccine reminders (BEHAVIORAL), Text message influenza and COVID-19 vaccine reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT06603090?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.